Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-019-1128-6, but it redirected us to https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-019-1128-6. The analysis below is for the second page.

Title[redir]:
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling | Molecular Cancer | Full Text
Description:
Background Pancreatic cancer is one of the most lethal types of cancer with extremely poor diagnosis and prognosis, and chemo-resistance remains a major challenge. The dynamic and reversible N6-methyladenosine (m6A) RNA modification has emerged as a new layer of epigenetic gene regulation. Methods qRT-PCR and IHC were applied to examine ALKBH5 levels in normal and pancreatic cancer tissues. Cancer cell proliferation and chemo-resistance were evaluated by clonogenic formation, chemosensitivity detection, and Western blotting assays. m6A-seq was performed to identify target genes. We evaluated the inhibitory effect of ALKBH5 in both in vivo and in vitro models. Results Here, we show that m6A demethylase ALKBH5 is downregulated in gemcitabine-treated patient-derived xenograft (PDX) model and its overexpression sensitized pancreatic ductal adenocarcinoma (PDAC) cells to chemotherapy. Decreased ALKBH5 levels predicts poor clinical outcome in PDAC and multiple other cancers. Furthermore, silencing ALKBH5 remarkably increases PDAC cell proliferation, migration, and invasion both in vitro and in vivo, whereas its overexpression causes the opposite effects. Global m6A profile revealed altered expression of certain ALKBH5 target genes, including Wnt inhibitory factor 1 (WIF-1), which is correlated with WIF-1 transactivation and mediation of the Wnt pathway. Conclusions Our work uncovers the tumor suppressive and chemo-sensitizing function for ALKBH5, which provides insight into critical roles of m6A methylation in PDAC.

Matching Content Categories {šŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {šŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of doi.org audience?

šŸš€ Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {šŸ’ø}

We find it hard to spot revenue streams.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {šŸ”}

alkbh, cells, cancer, wif, expression, pdac, fig, article, wnt, cell, google, scholar, pancreatic, signaling, additional, file, gemcitabine, figure, overexpression, aspc, tumor, modification, bxpc, mrna, rna, levels, mmp, mia, mice, control, cas, proliferation, protein, xenograft, paca, data, formation, qrtpcr, human, colony, wang, migration, treatment, methylation, genes, panc, quantification, analysis, cancers, invasion,

Topics {āœ’ļø}

augmented wnt/pi3k-akt signaling gemcitabine-treated patient-derived xenograft heat-induced antigen recovery treated-patient-derived xenograft poly-a-purified rna springer nature wnt/beta-catenin pathway wnt/β-catenin pathway wnt/beta-catenin signaling wnt/β-catenin signaling [27 wnt/β-catenin signaling avidin-biotin peroxidase complex considered statistically significant β-catenin protein levels kaplan-meier analysis indicating network-based methods alkbh5-mediated m6a modification gemcitabine-treated pdx model m6a-seq m6a-ip biological processes including additional information publisher β-catenin mrna transcripts privacy choices/manage cookies anti-α-catenin antibody chemo-resistance remains paraffin-embedded tissues cut genes differentially expressed mia paca-2-alkbh5 cells authors scientific editing including cell proliferation mediating methylation reversal bmc mediating wnt signaling human neuroendocrine tumors pancreatic ductal adenocarcinoma increased cell proliferation state privacy rights diminished promoter activations pancreatic cancer stem β-catenin promoter activity n6-methyladenosine mettl3 wnt signaling pathway cell proliferation program tumor growth rate cancer cell proliferation abbreviations alkbh5 pancreatic cancer cells dna damage repair bxpc-3 cells expressing cancer stem cell

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
         description:Pancreatic cancer is one of the most lethal types of cancer with extremely poor diagnosis and prognosis, and chemo-resistance remains a major challenge. The dynamic and reversible N6-methyladenosine (m6A) RNA modification has emerged as a new layer of epigenetic gene regulation. qRT-PCR and IHC were applied to examine ALKBH5 levels in normal and pancreatic cancer tissues. Cancer cell proliferation and chemo-resistance were evaluated by clonogenic formation, chemosensitivity detection, and Western blotting assays. m6A-seq was performed to identify target genes. We evaluated the inhibitory effect of ALKBH5 in both in vivo and in vitro models. Here, we show that m6A demethylase ALKBH5 is downregulated in gemcitabine-treated patient-derived xenograft (PDX) model and its overexpression sensitized pancreatic ductal adenocarcinoma (PDAC) cells to chemotherapy. Decreased ALKBH5 levels predicts poor clinical outcome in PDAC and multiple other cancers. Furthermore, silencing ALKBH5 remarkably increases PDAC cell proliferation, migration, and invasion both in vitro and in vivo, whereas its overexpression causes the opposite effects. Global m6A profile revealed altered expression of certain ALKBH5 target genes, including Wnt inhibitory factor 1 (WIF-1), which is correlated with WIF-1 transactivation and mediation of the Wnt pathway. Our work uncovers the tumor suppressive and chemo-sensitizing function for ALKBH5, which provides insight into critical roles of m6A methylation in PDAC.
         datePublished:2020-01-06T00:00:00Z
         dateModified:2020-01-06T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-019-1128-6
         keywords:
            Pancreatic cancer
            m6A methylation
            Chemo-resistance
            ALKBH5
            WIF-1
            Wnt
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig9_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Bo Tang
               affiliation:
                     name:The First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yihua Yang
               affiliation:
                     name:The First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Min Kang
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunshan Wang
               affiliation:
                     name:The Second Hospital of Shandong University
                     address:
                        name:Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan Wang
               affiliation:
                     name:The First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yin Bi
               affiliation:
                     name:The First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Songqing He
               affiliation:
                     name:The First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fumio Shimamoto
               affiliation:
                     name:Hiroshima Shudo University
                     address:
                        name:Department of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
      description:Pancreatic cancer is one of the most lethal types of cancer with extremely poor diagnosis and prognosis, and chemo-resistance remains a major challenge. The dynamic and reversible N6-methyladenosine (m6A) RNA modification has emerged as a new layer of epigenetic gene regulation. qRT-PCR and IHC were applied to examine ALKBH5 levels in normal and pancreatic cancer tissues. Cancer cell proliferation and chemo-resistance were evaluated by clonogenic formation, chemosensitivity detection, and Western blotting assays. m6A-seq was performed to identify target genes. We evaluated the inhibitory effect of ALKBH5 in both in vivo and in vitro models. Here, we show that m6A demethylase ALKBH5 is downregulated in gemcitabine-treated patient-derived xenograft (PDX) model and its overexpression sensitized pancreatic ductal adenocarcinoma (PDAC) cells to chemotherapy. Decreased ALKBH5 levels predicts poor clinical outcome in PDAC and multiple other cancers. Furthermore, silencing ALKBH5 remarkably increases PDAC cell proliferation, migration, and invasion both in vitro and in vivo, whereas its overexpression causes the opposite effects. Global m6A profile revealed altered expression of certain ALKBH5 target genes, including Wnt inhibitory factor 1 (WIF-1), which is correlated with WIF-1 transactivation and mediation of the Wnt pathway. Our work uncovers the tumor suppressive and chemo-sensitizing function for ALKBH5, which provides insight into critical roles of m6A methylation in PDAC.
      datePublished:2020-01-06T00:00:00Z
      dateModified:2020-01-06T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-019-1128-6
      keywords:
         Pancreatic cancer
         m6A methylation
         Chemo-resistance
         ALKBH5
         WIF-1
         Wnt
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1128-6/MediaObjects/12943_2019_1128_Fig9_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Bo Tang
            affiliation:
                  name:The First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yihua Yang
            affiliation:
                  name:The First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Min Kang
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunshan Wang
            affiliation:
                  name:The Second Hospital of Shandong University
                  address:
                     name:Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan Wang
            affiliation:
                  name:The First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yin Bi
            affiliation:
                  name:The First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Songqing He
            affiliation:
                  name:The First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fumio Shimamoto
            affiliation:
                  name:Hiroshima Shudo University
                  address:
                     name:Department of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:19
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:The First Affiliated Hospital of Guangxi Medical University
      address:
         name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:The Second Hospital of Shandong University
      address:
         name:Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China
         type:PostalAddress
      name:The First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:The First Affiliated Hospital of Guangxi Medical University
      address:
         name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:The First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
         type:PostalAddress
      name:Hiroshima Shudo University
      address:
         name:Department of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Bo Tang
      affiliation:
            name:The First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yihua Yang
      affiliation:
            name:The First Affiliated Hospital of Guangxi Medical University
            address:
               name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Min Kang
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yunshan Wang
      affiliation:
            name:The Second Hospital of Shandong University
            address:
               name:Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China
               type:PostalAddress
            type:Organization
      name:Yan Wang
      affiliation:
            name:The First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yin Bi
      affiliation:
            name:The First Affiliated Hospital of Guangxi Medical University
            address:
               name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Songqing He
      affiliation:
            name:The First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Fumio Shimamoto
      affiliation:
            name:Hiroshima Shudo University
            address:
               name:Department of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China
      name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Center of Reproductive Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
      name:Department of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan

External Links {šŸ”—}(286)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Prism.js

Emails and Hosting {āœ‰ļø}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {šŸ“¦}

  • Crossref

4.15s.